TMED vs. IHE
TMED (T. Rowe Price Health Care ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds. At a correlation of -0.17, they often move in opposite directions. TMED charges 0.44%/yr vs 0.42%/yr for IHE.
Performance
TMED vs. IHE - Performance Comparison
Loading charts...
Returns By Period
TMED
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IHE
- 1D
- 1.60%
- 1M
- 3.16%
- YTD
- 11.65%
- 6M
- 10.97%
- 1Y
- 46.87%
- 3Y*
- 18.43%
- 5Y*
- 10.55%
- 10Y*
- 8.99%
TMED vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
TMED T. Rowe Price Health Care ETF | -7.14% |
IHE iShares U.S. Pharmaceuticals ETF | 4.87% |
Correlation
The correlation between TMED and IHE is -0.17, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 4, 2026 | -0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. IHE — Risk / Return Rank
TMED
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IHE
TMED vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMED | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.46 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 5.56 | — |
| Martin ratioReturn relative to average drawdown | — | 17.09 | — |
Loading charts...
Drawdowns
TMED vs. IHE - Drawdown Comparison
The maximum TMED drawdown since its inception was -7.14%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for TMED and IHE.
Loading charts...
Drawdown Indicators
| TMED | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -7.14% | -38.20% | +31.06% |
Max Drawdown (1Y)Largest decline over 1 year | — | -8.47% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -15.92% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -16.03% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.59% | — |
Current DrawdownCurrent decline from peak | -7.14% | -0.70% | -6.44% |
Average DrawdownAverage peak-to-trough decline | -5.00% | -7.90% | +2.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.75% | — |
Volatility
TMED vs. IHE - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.27% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 12.68% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 66.28% | 17.22% | +49.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.28% | 16.28% | +50.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 66.28% | 18.05% | +48.23% |
TMED vs. IHE - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
TMED vs. IHE - Dividend Comparison
TMED has not paid dividends to shareholders, while IHE's dividend yield for the trailing twelve months is around 1.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.56% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
TMED T. Rowe Price Health Care ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and IHE have a correlation of -0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IHE is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IHE is cheaper with a 0.42% expense ratio, compared with 0.44% for TMED.
IHE has the higher dividend yield at 1.56%, compared with 0.00% for TMED.
They also come from different issuers: T. Rowe Price and iShares. Their fees differ too: 0.44% for TMED and 0.42% for IHE.
Find the right allocation for TMED and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer